EcoDrugPlus

Tryptophan Hydroxylase 1

Ensembl ID : ENSXMAG00000007103
Gene Symbol: TPH1
3 Cross references
207 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSXMAG00000015955
Gene Symbol: TUBA4A
3 Cross references
110 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSXMAG00000026340
Gene Symbol: TUBA4A
3 Cross references
170 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSXMAG00000022293
Gene Symbol: LOC111610383
2 Cross references
89 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSXMAG00000026750
Gene Symbol: LOC102237703
2 Cross references
184 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSXMAG00000015716
Gene Symbol: TP53
3 Cross references
231 Possible Orthologues:

Type-2 Angiotensin Ii Receptor-Like

Ensembl ID : ENSXMAG00000011919
Gene Symbol: LOC102224349
3 Cross references
185 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSXMAG00000011209
Gene Symbol: TYR
3 Cross references
202 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSXMAG00000017698
Gene Symbol: TYR
4 Cross references
198 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSXMAG00000025487
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSXMAG00000000220
Gene Symbol: TYK2
3 Cross references
195 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSXMAG00000011265
Gene Symbol: TIE1
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).